The content on this site is intended for healthcare professionals only
Dr Gregg Fields, speaks to ecancer at the Best of ASCO®️ 2024 Miami Symposium about trying to understand how cancer processes to the bone.
He discusses the process of bone re-modelling, cells called osteoclasts that remove bone, and cells called osteoblasts that fill in bone. Cancer cells high-jack osteoclasts, creating holes for the cancer to pass through.
Dr Fields goes on to discuss his design on compounds that prevents this process.
Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Isatuximab, plus bortezomib, lenalidomide, and dexamethasone shows improved PFS in frail NDMM patients
Choosing the right patients for transplant
Hormonal receptor positive breast cancer adjuvant and metastatic indications
A patient-reported questionnaire may eliminate the need for an ophthalmic exam before belantamab mafodotin dosing in TI NDMM
Importance of MRD in newly developed multiple myeloma
Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours
Relapsed refractory multiple myeloma
